Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News KALA BIO Inc KALA

Healthcare Biotechnology
KALA BIO, Inc. is a clinical-stage biopharmaceutical company. The Company is engaged in the research, development and commercialization of therapies for rare and severe diseases of the eye. The Company’s biologics-based investigational therapies utilize its proprietary mesenchymal stem cell secretome (MSC-S) platform. The Company’s product candidate, KPI-012, is a human MSC-S, which contains... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:KALA)

KALA BIO Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update

GlobeNewswire March 29, 2024

KALA BIO to Present at TD Cowen 44th Annual Healthcare Conference

GlobeNewswire February 26, 2024

KALA BIO to Present at Oppenheimer 34th Annual Healthcare Life Sciences Conference

GlobeNewswire February 6, 2024

KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire January 19, 2024

KALA BIO Reports Third Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire November 13, 2023

KALA BIO Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

GlobeNewswire September 20, 2023

KALA BIO to Present at H.C. Wainwright 25th Annual Global Investment Conference

GlobeNewswire September 5, 2023

KALA BIO Reports Second Quarter 2023 Financial Results and Provides Corporate Update

GlobeNewswire August 4, 2023

KALA BIO to Participate in Upcoming Investor Conferences in August

GlobeNewswire August 2, 2023
View More News ››

Opinion & Analysis (NDAQ:KALA)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:KALA)

KALA..... Now if I had just held those 500 shares at $6

I coulda been a contendah ; )
Iseneschal - January 4, 2023

KALA..... Can't halt progress ; )

Scalped the cr*p out of this today.... LoL....No skiing for me today.... made a chit ton of dough today. Still in my robe....no breakfast...
Iseneschal - December 29, 2022

RE:KALA ..... It held and was halted and rallied

What a run !!
moosesdad - December 28, 2022

KALA .....unreal !!!!

How sweet is this? Now at congestion dating back to last May pre-reverse split I got lucky being a seller !!!!
Iseneschal - December 28, 2022

KALA ..... I'm rich !!!!!!!!!!!

Yeeha !
Iseneschal - December 28, 2022

KALA ..... It held and was halted and rallied

Cheers to the Bulls
Iseneschal - December 28, 2022
View more Bullboard ››

Royalties Inc.

Royalties Inc.

Royalties Inc. is focused on seeking cash flow generating royalty opportunities in various industries. While the Issuer’s ...
View More »